An overview of current delivery systems in cancer gene therapy.
about
Current applications of graphene oxide in nanomedicineLipid Nanoparticles for Ocular Gene DeliveryStrategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketMobile DNA and evolution in the 21st centuryGeneral synthesis and physicochemical characterisation of a series of peptide-mimic lysine-based amino-functionalised lipids.Carbon Nanotubes as an Effective Opportunity for Cancer Diagnosis and Treatment.Enhanced siRNA delivery using a combination of an arginine-grafted bioreducible polymer, ultrasound, and microbubbles in cancer cells.Establishment of mass spectrometric fingerprints of novel synthetic cholesteryl neoglycolipids: the presence of a unique C-glycoside species during electrospray ionization and during collision-induced dissociation tandem mass spectrometry.Endogenous HIV-1 Vpr-mediated apoptosis and proteome alteration of human T-cell leukemia virus-1 transformed C8166 cells.Advancement and prospects of tumor gene therapySiRNA Delivery with PEGylated Graphene Oxide Nanosheets for Combined Photothermal and Genetherapy for Pancreatic Cancer.Tertiary-amine functionalized polyplexes enhanced cellular uptake and prolonged gene expression.Efficient delivery of plasmid DNA using cholesterol-based cationic lipids containing polyamines and ether linkages.A facile approach to construct hybrid multi-shell calcium phosphate gene particlesAFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study.Nanopharmacology in translational hematology and oncologyRe-engineered p53 chimera with enhanced homo-oligomerization that maintains tumor suppressor activity.Nanoparticle-assisted targeted delivery of eye-specific genes to eyes significantly improves the vision of blind mice in vivo.Development and characterization of pectinate micro/nanoparticles for gene deliveryViral and nonviral delivery systems for gene deliveryGlioma cell growth inhibition following photochemical internalization enhanced non-viral PTEN gene transfection.Improvement of different vaccine delivery systems for cancer therapy.A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphomaComet assay: a method to evaluate genotoxicity of nano-drug delivery system.Highly effective gene transfection in vivo by alkylated polyethylenimine.An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude miceSafety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor modelReceptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.Quantitative nanoparticle tracking: applications to nanomedicine.Nonclinical evaluation of novel cationically modified polysaccharide antidotes for unfractionated heparinThe development and assessment of high-throughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate.Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer.Developing a Novel Gene-Delivery Vector System Using the Recombinant Fusion Protein of Pseudomonas Exotoxin A and Hyperthermophilic Archaeal Histone HPhA.Vaccines that facilitate antigen entry into dendritic cells.Targeting dendritic cells with antigen-containing liposomes: antitumour immunity.Cytofectin amine head group modification and degree of liposome pegylation: factors influencing gene transfer.An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastomaDevelopment of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer.Microarc-oxidized titanium surfaces functionalized with microRNA-21-loaded chitosan/hyaluronic acid nanoparticles promote the osteogenic differentiation of human bone marrow mesenchymal stem cells.Amphiphilic graft copolymer based on poly(styrene-co-maleic anhydride) with low molecular weight polyethylenimine for efficient gene delivery
P2860
Q26783225-F4128F6C-FE45-49DA-8BD0-4772914D39C0Q26823895-A0A69B0A-3324-4B69-BEF0-49CD493A7080Q27015050-8CE089DE-7721-4902-98D5-295E842D386EQ28748605-7BDF8968-1605-459F-A131-5A0D877F5904Q30317751-13265D80-CBB9-4221-977B-1A83EB808731Q30359017-E839A721-5DDC-4D29-863D-7A4875426E49Q30438863-75154DD2-3588-4AA7-9479-8DF6BEF24BCAQ33436168-DE38470E-B349-448A-A3C5-387768D36598Q33490665-AE4822F9-0ADE-4487-A5D7-7872DB950453Q33579330-4E4521BD-8CB6-4433-992F-A933A6EF9648Q33588169-CBEBA22B-4426-43A8-B986-BCB970099CA6Q33610596-7D7C4E1D-5464-48CD-90CC-3B8407EF65A7Q33755551-F3AEF1B5-FA51-4023-8542-FB3416530AADQ33781046-C2D64F4E-9EFA-4CC4-AA4B-5B7C841F8377Q33863677-CF085FE1-66C9-4A34-A950-52D07E10554DQ33961538-0BFD8820-D889-4C0D-8DE9-2CE7BB5660D5Q33966877-70A2FC33-7D8D-4BAE-87B3-1D15C3263813Q34160426-CC92ADF0-94C1-41EF-95BF-DF17ED8574BAQ34293392-06EB6DC4-26BC-4B92-942F-B26D96DCC444Q34315475-4AB1256A-ECDB-4DEC-9383-76C40DC08A90Q34423421-7B4C7842-58D9-4973-80D6-27CEBDAE486DQ34506877-0BEFE012-BE12-49B1-BF73-CA40434D1866Q34607749-93463051-01CD-4736-8C4E-231C27071900Q34725253-CDE28C8F-6361-4E4E-A6C0-AFB94448B0CCQ34730046-9656A5DB-9F94-4B07-8438-9550CD391A71Q34901473-0467C09D-9179-4E85-A5E1-2CE402296B4DQ34959758-711FD9D0-D9D4-48A1-AD78-E4228E9ED5A3Q35129377-BC2851B1-4A45-43F3-9B8D-17B9F863B130Q35163996-078F6BCD-102C-49FE-B203-0C3B0CCA2F20Q35185880-387E899F-6338-4B8F-89D9-D71669101799Q35419675-EBA184F7-534A-46D9-85E4-77D9EA28A2CBQ35794644-3E98F89B-909D-4AC0-B619-6B5D30D57785Q35837728-274B63C4-927D-4509-A9E7-4CDAA2EBC550Q35915763-5A05F49F-A2B0-4580-AD3B-4F8238912E03Q35925604-146127DD-FF99-4AB9-917D-56EB8820CCF0Q36029823-0A26753F-DCF8-43C9-BC6A-AF2263AF0FCBQ36093931-52CF9B02-744C-4A58-A72B-9E16D9CF5709Q36119526-0829F61C-65C5-4FE4-9799-A1115BC19904Q36240683-4834912C-3762-4107-B90E-2E4994CADF87Q36247150-C27FA116-1DCD-406A-95B1-4CA725F1FC6F
P2860
An overview of current delivery systems in cancer gene therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
An overview of current delivery systems in cancer gene therapy.
@ast
An overview of current delivery systems in cancer gene therapy.
@en
type
label
An overview of current delivery systems in cancer gene therapy.
@ast
An overview of current delivery systems in cancer gene therapy.
@en
prefLabel
An overview of current delivery systems in cancer gene therapy.
@ast
An overview of current delivery systems in cancer gene therapy.
@en
P1476
An overview of current delivery systems in cancer gene therapy.
@en
P2093
Anas El-Aneed
P356
10.1016/J.JCONREL.2003.09.013
P407
P577
2004-01-01T00:00:00Z